Skip to main content

Branded

  • J&J adds pain drug resources to responsible prescribing site

    RARITAN, N.J. — Johnson & Johnson has launched several new tools on a website aimed at ensuring patients with pain get the drugs they need while staying safe.

    J&J subsidiary Janssen Pharmaceuticals added resources and tools to PrescribeResponsibly.com for physicians and pharmacists to support appropriate and responsible treatment of pain. The site was originally launched early last year.

  • Winn-Dixie announces flu shot availability

    JACKSONVILLE, Fla. — Winn-Dixie Stores on Wednesday announced that flu vaccinations are now available in all Winn-Dixie in-store pharmacies to help prepare guests for the upcoming flu season. Guests will receive the flu vaccine for the discounted rate of $24.99 when purchased using their Winn-Dixie Customer Reward Card.

  • FDA approves drug, diagnostic test for melanoma

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug and companion diagnostic test for the most dangerous type of skin cancer, the agency said Wednesday.

    The FDA announced the approval of Genentech's and Daiichi Sankyo's Zelboraf (vemurafenib), for patients with late-stage melanoma that can't be removed by surgery. Genentech is the U.S. division of Swiss drug maker Roche.

  • American Diabetes Association, Lilly team for annual Victory Over Diabetes event

    ATLANTA — The American Diabetes Association, with help from drug maker Eli Lilly, once again is hosting a free communitywide event in Atlanta that's designed to educate African-Americans on diabetes management.

  • Savient gout drug shows improvements, according to study

    EAST BRUNSWICK, N.J. — Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.

  • Study: Effient reduces cardiovascular risk among younger, heavier patient cohort

    INDIANAPOLIS — A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.

  • Pharmaca debuts vaccine offerings

    BOULDER, Colo. — Pharmaca Integrative Pharmacy on Tuesday announced that it is now offering immunizations for influenza, pneumonia and whooping cough on a walk-in basis. The majority of Pharmaca’s pharmacists are trained to provide the shots to any customer who requests one during open pharmacy hours.

    In addition, Pharmaca will hold Flu Shot Clinics every Tuesday in September, October and November, between 2 p.m. and 6 p.m.

  • Study: Investigational GSK, Impax drug reduces Parkinson's symptoms

    HAYWARD, Calif. — Patients taking an experimental treatment for Parkinson's disease experienced greater reduction in symptoms than those taking a drug already on the market, according to results of a late-stage clinical trial.

X
This ad will auto-close in 10 seconds